Gambogenic acid
Gambogenic Acid, identified from Gamboge, is an inhibitor of the FGFR signaling pathway in erlotinib-resistant non-small-cell lung cancer (NSCLC) and exhibits anti-tumor effects. Gambogenic acid acts is also an effective inhibitor of EZH2 that specifically and covalently binds to Cys668 within the EZH2-SET domain, and triggers EZH2 ubiquitination.
| Trivial name | N/A |
| Catalog Number | S9031 |
| Molecular Formula | C38H46O8 |
| CAS# | 173932-75-7 |
| Inchi | InChI=1S/C38H46O8/c1-20(2)10-9-11-22(5)13-15-25-30(39)26(14-12-21(3)4)33-29(31(25)40)32(41)27-18-24-19-28-36(7,8)46-37(34(24)42,38(27,28)45-33)17-16-23(6)35(43)44/h10,12-13,16,18,24,28,39-40H,9,11,14- 15,17,19H2,1-8H3,(H,43,44)/b22-13+,23-16-/t24-,28+,37+,38-/m1/s1 |
| Inchi Key | RCWNBHCZYXWDOV-VSFMGBBVSA-N |
| SMILES | CC(=CCCC(=CCC1=C(C(=C2C(=C1O)C(=O)C3=CC4CC5C3(O2)C(C4=O)(OC5(C)C)CC=C(C)C(=O)O)CC=C(C)C)O)C)C |
| Size | 10mg |
| Supplier Page | http://www.selleckchem.com/products/gambogenic-acid.html |
| Additional Information | https://file.selleck.cn/downloads/struct/gambogenic-acid-chemical-structure-s9031.gif |